Condition: Testicular Germ Cell Tumor · Sponsor: Fondazione del Piemonte per l'Oncologia
This is a observational study aimed at evaluating miRNA 371a-3p (miRNA 371) as a specific marker for presence or absence of clinically detectable viable germ cell malignancy.
This description comes directly from the study's public registry record.
Pasquale Rescigno, MD · +390119933601 · pasquale.rescigno@ircc.it
Ilaria Buondonno, PhD · +390119933393 · ilaria.buondonno@ircc.it
Always discuss trial participation with your own doctor first.
| Fondazione del Piemonte per l'Oncologia | Candiolo, Turin, Italy | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07453082